Literature DB >> 30610037

Pregnancy, malignancy or mother nature? Persistence of high hCG levels in a perimenopausal woman.

Ayşe Y Demir1, Ruben Ea Musson2, Willem A Schöls3, Jitze M Duk3.   

Abstract

Despite the fact that a small percentage of peri en postmenopausal women have mild elevations in human chorionic gonadotrophin (hCG) concentrations (<14 IU/L) besides high levels of gonadotrophins, a considerable number of clinicians are not aware of this phenomenon. We report a case of a 53-year-old woman with an unusually high hCG concentration (>40 IU/L) given her menopausal state. Although a pregnancy or a malignancy was unlikely on the basis of stable hCG levels, elevated gonadotrophins and a negative transvaginal ultrasound, her physicians were uncertain and chose an expectant approach by repeated testing. Ultimately, after consulting the laboratory, analytical interference was ruled out and pituitary origin of unusual high hCG level could be confirmed after conduction of a suppression test by oestrogen-progesterone hormone replacement therapy. Until that time, the patient had undergone a vast amount of laboratory tests and gynaecology consultations, resulting in an enormous amount of confusion, anxiety and overdiagnosis. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  menopause (including Hrt); pituitary disorders; pregnancy

Mesh:

Substances:

Year:  2019        PMID: 30610037      PMCID: PMC6326279          DOI: 10.1136/bcr-2018-227203

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  21 in total

1.  False diagnosis and needless therapy of presumed malignant disease in women with false-positive human chorionic gonadotropin concentrations.

Authors:  S Rotmensch; L A Cole
Journal:  Lancet       Date:  2000-02-26       Impact factor: 79.321

2.  Normal production of human chorionic gonadotropin in menopause.

Authors:  Laurence A Cole; Yasushi Sasaki; Carolyn Y Muller
Journal:  N Engl J Med       Date:  2007-03-15       Impact factor: 91.245

3.  False-positive hCG assay results leading to unnecessary surgery and chemotherapy and needless occurrences of diabetes and coma.

Authors:  L A Cole; K M Rinne; S Shahabi; A Omrani
Journal:  Clin Chem       Date:  1999-02       Impact factor: 8.327

4.  Interference in human chorionic gonadotropin (hCG) analysis by macro-hCG.

Authors:  Annemieke C Heijboer; Frans Martens; Sandra D Mulder; Roel Schats; Marinus A Blankenstein
Journal:  Clin Chim Acta       Date:  2011-08-08       Impact factor: 3.786

5.  Three pregnancies despite elevated serum FSH and advanced age: case report.

Authors:  J H Check; M L Check; D Katsoff
Journal:  Hum Reprod       Date:  2000-08       Impact factor: 6.918

Review 6.  False-positive serum human chorionic gonadotropin (HCG) in a male patient with a malignant germ cell tumor of the testis: a case report and review of the literature.

Authors:  Bart E P B Ballieux; Nir I Weijl; Hans Gelderblom; Johannes van Pelt; Susanne Osanto
Journal:  Oncologist       Date:  2008-11-04

7.  Serum levels of human chorionic gonadotropin in nonpregnant women and men are modulated by gonadotropin-releasing hormone and sex steroids.

Authors:  U H Stenman; H Alfthan; T Ranta; E Vartiainen; J Jalkanen; M Seppälä
Journal:  J Clin Endocrinol Metab       Date:  1987-04       Impact factor: 5.958

Review 8.  Human chorionic gonadotropin in cancer.

Authors:  Ulf-Håkan Stenman; Henrik Alfthan; Kristina Hotakainen
Journal:  Clin Biochem       Date:  2004-07       Impact factor: 3.281

Review 9.  False-positive serum human chorionic gonadotropin results: causes, characteristics, and recognition.

Authors:  Glenn D Braunstein
Journal:  Am J Obstet Gynecol       Date:  2002-07       Impact factor: 8.661

10.  Rapid, automated quantification of total human chorionic gonadotropin in serum by a chemiluminescent enzyme immunometric assay.

Authors:  L Vankrieken; R De Hertogh
Journal:  Clin Chem       Date:  1995-01       Impact factor: 8.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.